Five members of South Korea's ruling party supported the impeachment of Yin Xiyue. Kim Jae-sub, a member of South Korea's ruling National Power Party, announced through live television that he would no longer abide by the ruling party's position of opposing the impeachment of President Yin Xiyue and would vote in favor of the next presidential impeachment case. At present, five members of South Korea's ruling party have indicated that they will support the impeachment of President Yin Xiyue. There are 300 seats in South Korea's National Assembly, and the impeachment case of the President must obtain at least 2/3, that is, at least 200 members vote in favor before it can pass the National Assembly and enter the trial stage of the Korean Constitutional Court. At present, South Korea's parliament, including the largest opposition party, the Common Democratic Party, has 192 seats in the opposition camp and 108 seats in the ruling party. On the premise that all members of the opposition camp voted for impeachment, only eight members of the ruling party voted for it, and Yin Xiyue's impeachment case will pass the parliament. At present, three members of parliament from the ruling party need to vote for impeachment. (CCTV International News)At the opening of the night session, the main contract of No.20 glue rose by nearly 2%, and the main contracts of low sulfur fuel oil (LU) and coking coal rose by over 1%. In terms of decline, the main contract of alumina fell by more than 1%, and the main contract of palm oil and soybean meal fell by nearly 1%.Market News: US Secretary of State Blinken will travel to Jordan and Turkey for talks on the Syrian issue on Wednesday.
Kremlin: We keep in touch with those who control the situation in Syria.Tesla Applied for the trademark of robot action toy, and the enterprise search app showed that Tesla Co., Ltd. recently applied for registering a trademark of "TESLA BOT ACTION FIGURE", which is classified as fitness equipment internationally. At present, the trademark status is in the process of registration application. According to media reports, recently, Tesla robot action toys were sold in official stores for 40 dollars. According to the official description, the toy is a "mini version" of Optimus Gen 2 humanoid robot, which is made in a ratio of 1:10.CITIC Bank: Redemption of open-ended capital bonds. CITIC Bank announced that from December 9 to December 11, 2019, it issued RMB 40 billion of open-ended capital bonds (hereinafter referred to as "current bonds"), and on December 12, 2019, it issued the Announcement of China CITIC Bank Corporation on the Completion of Issuance of Open-ended Capital Bonds. According to the relevant provisions of the prospectus of this issue, this issue has the issuer's conditional redemption right, and the issuer has the right to redeem this issue in whole or in part on the interest payment date of the fifth year of this issue, that is, December 11, 2024. As of the date of this announcement, with the approval of the State Financial Supervision and Administration, the Bank has exercised the right of redemption and redeemed the bonds in full.
The China Securities Association held a plenary meeting of the professional committee on securities brokerage, wealth management and asset management, which was held in Beijing on December 3rd. The meeting stressed that the securities industry should focus on its main business, optimize supply, improve its value creation ability, form a diversified financial product and service system suitable for the needs of various investors, and implement the strategic layout of "five big articles"; Adhere to the customer-centered, practice the development concept of finance serving the country and finance serving the people, and correctly handle the relationship between functionality and profitability; Actively serve the national strategic needs, optimize product design, innovate service models, and provide more long-term financial support for the real economy. The meeting summarized the key work of the Committee in 2024 and discussed the work plan for 2025. In the next stage, the Committee will further play its role as a platform for communication, deliberation and handling affairs, unite industry consensus, guide the industry to focus on its main business, give full play to the functions of wealth managers, continuously improve its professional service capabilities, provide full chain services for investors' property preservation and appreciation, and help the high-quality development of the capital market.Jinfei Kaida: The controlling shareholder plans to increase the company's shares by RMB 50 million to RMB 100 million. Jinfei Kaida (002863) announced on the evening of December 11th that the controlling shareholder Jinfei Holdings plans to increase the company's shares by RMB 50 million to RMB 100 million. Jinhua Branch of China Construction Bank Co., Ltd. issued the "China Construction Bank Loan Commitment Letter" to Jinfei Holdings on December 10th, promising to provide Jinfei Holdings with a special loan of no more than 90 million yuan for stock increase, with a loan period of 3 years.The Shanghai Stock Exchange approved the refinancing of Dizhe Medicine to support the development of new quality productivity. The announcement of Dizhe Medicine shows that the private placement plan of Dizhe Medicine in science and technology innovation board has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of unprofitable enterprises in Shanghai Stock Exchange has been approved since the issuance of the Eight Measures on Deepening science and technology innovation board's Reform, Service, Scientific and Technological Innovation and Development of New Productivity by CSRC. As a listed company with the fifth standard in science and technology innovation board, Dizhe Medicine's refinancing has been approved by Shanghai Stock Exchange, which reflects the institutional inclusiveness and support of the capital market for supporting new quality productivity and unprofitable technology-based enterprises with key core technologies, great market potential and outstanding scientific and technological attributes. Dizhe Medicine said that the company's refinancing will help the company to further accelerate product research and development and production base construction, create new quality productivity, implement major national strategies, promote products to the sea, and give scientific and technological impetus to the development of biomedical economy. (Sina Technology)